Cagrilintide GLP-1 S 2.5MG 2.5MG

Categories:

Cagrilintide GLP-1 S is a research-use-only peptide in a 2.5MG formulation, designed for laboratory investigation. This product is intended solely for academic and scientific research in controlled environments. For research use only.

$32.00

Satisfaction Guaranteed

Secure
Payment

Third-party
Tested

⚠️ RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

Cagrilintide GLP-1 Analog – Research-Use-Only Peptide

Cagrilintide is a novel GLP-1 (Glucagon-Like Peptide-1) receptor agonist under investigation in preclinical research for its potential role in metabolic studies. This peptide analog, derived from the human GLP-1 family, has been examined for its ability to modulate appetite regulation, glucose metabolism, and gastrointestinal motility. As a research-use-only compound, this product is intended solely for academic and institutional scientific investigations, not for therapeutic or commercial applications.

Research Context

GLP-1 receptor agonists have emerged as key targets in metabolic research due to their established roles in modulating insulin secretion, glucose homeostasis, and satiety. Traditional GLP-1 analogs, such as exendin-4, demonstrate efficacy in animal models of obesity and diabetes. Cagrilintide represents a novel variant designed to explore enhanced selectivity, pharmacokinetic properties, and potential therapeutic windows beyond conventional GLP-1 analogs.

Research Overview

Cagrilintide is characterized by its dual functionality as both a GLP-1 and glucagon receptor agonist, offering a distinct pharmacological profile compared to monovalent GLP-1 agonists. Preclinical studies have demonstrated its potential utility in evaluating gastrointestinal transit, pancreatic hormone responses, and weight regulation mechanisms. The peptide’s stability and metabolic clearance profile are critical factors in its application within experimental metabolic research.

Key Research Focus Areas

  • Metabolic Regulation: Investigation of appetite suppression and glucose homeostasis through GLP-1 receptor-mediated pathways.
  • Gastrointestinal Motility: Assessment of peptide-induced effects on gastric emptying and intestinal transit in preclinical models.
  • Hormonal Cross-Talk: Evaluation of interactions between GLP-1 and glucagon signaling in pancreatic and gastrointestinal tissues.
  • Pharmacokinetic Stability: Characterization of peptide degradation, half-life, and receptor-binding affinity in experimental settings.

Safety and Compliance

This peptide is provided for academic research purposes only. Researchers are responsible for ensuring compliance with institutional review boards, regulatory guidelines, and ethical standards governing peptide experimentation. Due to its potential for unintended biological effects, proper experimental controls and safety protocols must be implemented. Users must adhere to strict research-use-only protocols and not utilize the product for any non-academic applications.

For research use only. Not for human or animal consumption.

Reviews

There are no reviews yet.

Be the first to review “Cagrilintide GLP-1 S 2.5MG 2.5MG”

Your email address will not be published. Required fields are marked *

Related Products